covid-19

SARS-CoV-2, like many other pathogens, needs to be at a certain vaccine dose in order for it to trigger an infection and immune response in an infected individual. A low dose may allow an individual to respond to a virus successfully, while a dose that is too high can potentially make a person…

Researchers discovered that many COVID-19 patients develop “autoantibodies” which target human cells instead of virus cells. This could explain why some survivors have lasting problems even after recovering from the virus. It is possible that even a mild response to the virus could induce the…

The CDC’s Advisory Committee on Immunization Practices met to discuss how to best distribute a COVID-19 vaccine once one is approved. They identified four groups that would have priority vaccination. The first group to be vaccinated would be health care personnel due to their close proximity and…

The University of Oxford and Astra Zeneca are collaborating on the development of a coronavirus vaccine. With recent evidence, their vaccine appears to be one of the frontrunners for a vaccine available by the end of the year. Recent studies showed that an immune response was developed in response…

In early September, President Trump predicted that there would be a coronavirus vaccine available before the election on November 3rd. Although new drugs typically go through lengthy and rigorous trials before approval, vaccines for COVID-19 are expected to be released under emergency use…

Two COVID-19 vaccine trials are currently paused due to concerns about its side effects. AstraZeneca's U.S. trial of its vaccine has been stalled for over a month after two volunteers developed neurological conditions, though it is unconfirmed how the conditions arose. Likewise, this Monday,…

As speculated, the United States has met a new COVID-19 surge, one that could inflict an even greater toll on a mass scale. According to Dr. Peter Hotez, there are 50,000 new cases a day, in contrast to the lowest cases in September averaging around 30,000 to 35,000 new case a day. Over 30 states -…

A new study by the World Health Organization showed that the antiviral drug Remdesivir, which was previously granted emergency authorization by the Food and Drug Administration, fails to prevent death among COVID-19 patients. The study’s manuscripts suggest that the results of Remdesivir were…

As the fall season approaches, the public must remain vigilant amidst colder weather, reopened schools, and loosening restrictions. Some ways to stay safe are to limit your physical contact to just a small group of friends or family and to leave large gatherings to a virtual platform. It is also a…

Tensions within the Spanish government rise as they work to fight the new wave of COVID-19 outbreaks. A state of emergency has been declared in the Madrid region. For more information, click here.

Various pharmaceutical companies are on the race to make a successful coronavirus vaccine. Rushed clinical trials were allowed in order to speed up the process of vaccine development, but it also comes with great risks; it makes it difficult to determine which vaccine is better than the other,…

Dr. Facui has projected a rising number of Covid-19 cases in dozens of states. In fact, he predicts another 181,000 deaths in the U.S. by February 2021. As the cold winter season approaches, experts are worried that people will begin to spend much more time indoors, causing the virus to spread more…

The journalists at Washington Post are constantly updating this article site with new information about the possible vaccines for coronavirus. There are currently 10 Vaccines in Phase 3 of trials. The FDA states that in order for a vaccine to be approved, the prevention or decrease of symptoms in…

Many potential Covid-19 vaccines utilize oil from sharks called squalene. It is taken from shark livers and typically used as a moisturizing ingredient in cosmetics and as an immune system booster in flu and malaria vaccines. Conservationists warn that if the coronavirus vaccine with squalene is…